MR imaging of pituitary adenoma: CT, clinical, and surgical correlation.
Twenty-five patients with suspected pituitary adenoma were evaluated prospectively with CT and MR. Nine patients underwent transsphenoidal surgery, and three of these showed a documented decrease in size of mass on bromocriptine therapy. CT was more sensitive than MR for detecting focal lesions (seven vs three) and sellar-floor erosion (12 vs six). MR was superior to CT in identifying infundibular abnormalities (seven vs six), focal abnormalities of the diaphragma sellae (10 vs seven), cavernous sinus invasion (four vs two), and optic chiasm compression (six vs zero). Thus, MR may be the procedure of choice for optimal identification and localization of macroadenoma. For patients with suspected microadenoma, however, this preliminary series indicates that CT remains the radiographic procedure of choice.
D000236:Adenoma / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D001971:Bromocriptine / Q000627:therapeutic use; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D010911:Pituitary Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000601:surgery; D011388:Prolactin / Q000378:metabolism; D011446:Prospective Studies; D013101:Sphenoid Sinus / Q000601:surgery; D014057:Tomography, X-Ray Computed
D001971:Bromocriptine; D000324:Adrenocorticotropic Hormone; D011388:Prolactin